A novel potent class I HDAC inhibitor reverses the STAT4/p66Shc apoptotic defect in B cells from chronic lymphocytic leukemia patientsSara Rossi, Giuseppe Campiani, Maria Dichiara et al.|Biomedicine & Pharmacotherapy|2024Cited by 9
p66Shc deficiency in CLL cells enhances PD-L1 expression and suppresses immune synapse formationLudovica Lopresti, Laura Patrussi|Frontiers in Cell and Developmental Biology|2024Cited by 6